+8615710194249

News Center

Cai Ji

2024-01-29

Mr. Cai Ji, Director of Manufacturing Science and Technology Department, is responsible for the GMP production of the company's clinical filing projects and clinical study drugs. He has nearly 10 years of experience in downstream purification process development, GMP production and project management. As the project leader of Afamelanotide, he was responsible for the whole process from process development to NDA filing. Worked as a key participant in the full process from process development to NDA filing in the EU for the drug API Bulevirtide, a drug pipeline that was later acquired by Gilead. During his tenure, as a project leader, he was responsible for the process development and manufacturing of 10~20 IND PhaseI~PhaseII drugs per year. As a GMP Production Director, he has managed nearly 100 employees under the production department and has many years of experience in people management and project management. Since joining Immorna, he has completed the GMP manufacturing of four FDA IND projects and was responsible for writing some of the filings. She has also completed one IND filing and two IIT clinical drug manufacturing projects in China.